MedTrace Logo

Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

NCT05804578 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-07-25

No results posted yet for this study

Summary

The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.

Conditions

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Queen's University

    collaborator OTHER

  • Dr. Christopher Mueller

    lead OTHER

Principal Investigators

  • Christopher R Mueller, Ph.D. · Queen's University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-19
Primary Completion
2026-01-31
Completion
2026-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05804578 on ClinicalTrials.gov